Childhood Asthma: This Blood Marker in Pregnant Women Could Change Everything

A recent study sheds light on the crucial role of a molecule present in the blood of expectant mothers for children's health. By identifying this marker, scientists hope to better prevent asthma and pulmonary infections from an early age through personalized solutions.

12-HETE as a Guardian of Respiratory Health

Everything revolves around a molecule with a somewhat complex name: 12-HETE. This compound, derived from the degradation of fatty acids, has been closely scrutinized by researchers in a study published in the journal Cell Reports Medicine. By analyzing the blood of over 1,500 pregnant women during their second trimester, scientists observed a striking phenomenon.

When this molecule is absent or present in minimal amounts in maternal blood around the 24th week of pregnancy, the chances of the child developing asthma before the age of ten jump by 62%.

Children born to mothers with these low levels also appear to be more vulnerable to external aggressions right from birth. They are statistically more prone to early respiratory infections, such as recurrent colds or bronchiolitis, which often disrupt the early years of parenting. This molecule would actually act as an early warning signal, indicating a pulmonary vulnerability that establishes itself well before the newborn's first cry.

Baby's Immunity Programs Itself from In-Utero Life

It is now known that the maternal womb is not an isolated bubble but a true learning environment for the fetus's immune system. 12-HETE would play a conducting role in lung development. To understand the mechanism, one must look at the alveolar macrophages, those protective cells that stand guard in our bronchi. In the absence of this marker in the mother, these little soldiers of the immune system would not receive the right instructions, leaving the field open for future chronic inflammation.

This maternal deficiency has another direct consequence: it alters the composition of the infant's respiratory microbiota. Babies whose mothers lacked this molecule present different bacterial profiles from their earliest weeks of life, with a more pronounced presence of certain bacteria often associated with respiratory disorders.

Dietary Supplements Require a Personalized Approach

This is undoubtedly the point that will interest parents who are keen on supplementation: the impact of omega-3s. It is often said that taking fish oil during pregnancy is a miracle solution for the baby's lungs. The study brings a significant nuance that completely changes the perspective. While omega-3s do significantly reduce the risk of asthma in some children, this protective effect is only observed in mothers who already have a sufficient level of 12-HETE.

This means that a one-size-fits-all approach for all pregnant women may not be the most effective. This discovery paves the way for precision medicine, much more respectful of each body's individuality. In the future, a simple blood test could determine whether an omega-3 regimen will truly be beneficial for your future child or if other preventive strategies need to be implemented.